PTH and Marchiafava-Bignami disease: Chronic kidney disease–mineral and bone disorders (CKD-MBD), marked by disturbances in mineral metabolism including phosphate, calcium and parathyroid hormone (PTH) levels, are prevalent complications among dialysis patients.